Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN4A | P35499 | 2/20 | 0.49 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.47 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.47 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.36 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | GRAMD1A | Q96CP6 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24061284 | 1.00 | SCN4A (0.49) | SCN4ASCN3ASCN5AMAP4K4ADORA1 | |
| SCHEMBL31569400 | 0.86 | SCN4A (0.36) | SCN4ASCN3ASCN5AMAP4K4ADORA1 | |
| SCHEMBL31569367 | 0.86 | SCN4A (0.36) | SCN4ASCN3ASCN5AMAP4K4ADORA1 | |
| SCHEMBL31568968 | 0.85 | SCN4A (0.36) | SCN4ASCN3ASCN5AMAP4K4ADORA1 | |
| SCHEMBL22273700 | 0.84 | SCN3A (0.46) | SCN4ASCN3ASCN5AMAP4K4ADORA1 | |
| SCHEMBL31568970 | 0.84 | SCN4A (0.35) | SCN4ASCN3ASCN5AMAP4K4ADORA1 | |
| SCHEMBL31569524 | 0.84 | MEN1 (0.37) | SCN4ASCN3ASCN5AMAP4K4ADORA1 | |
| SCHEMBL31569443 | 0.82 | GRAMD1A (0.39) | SCN4ASCN3ASCN5AMAP4K4MEN1 | |
| SCHEMBL31569174 | 0.82 | SCN4A (0.35) | SCN4ASCN3ASCN5AMAP4K4ADORA1 | |
| SCHEMBL31569513 | 0.82 | SCN4A (0.37) | SCN4ASCN3ASCN5AMAP4K4ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025101780-A1 | PHARMACOLOGICAL CORRECTORS OF RHODOPSIN AND USES THEREOF | OCTANT, INC. (US) | 2025-05-15 | — | — | WO | disclosed |
| US-20200354379-A1 | NOVEL, HIGHLY ACTIVE AMINO-THIAZOLE SUBSTITUTED INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV) | AICURIS GMBH & CO. KG (DE) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354379-A1 | NOVEL, HIGHLY ACTIVE AMINO-THIAZOLE SUBSTITUTED INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV) | HCCS, CDK2, BRD4 | SCN4A 4343/4885SCN3A 4491/4885SCN5A 4055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.